Enveric Biosciences Stock Market Value
| ENVB Stock | USD 2.42 1.24 105.08% |
| Symbol | Enveric |
Enveric Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enveric Biosciences. If investors know Enveric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enveric Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (36.30) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
The market value of Enveric Biosciences is measured differently than its book value, which is the value of Enveric that is recorded on the company's balance sheet. Investors also form their own opinion of Enveric Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Enveric Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enveric Biosciences' market value can be influenced by many factors that don't directly affect Enveric Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enveric Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enveric Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enveric Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Enveric Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Enveric Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Enveric Biosciences.
| 01/27/2025 |
| 02/26/2025 |
If you would invest 0.00 in Enveric Biosciences on January 27, 2025 and sell it all today you would earn a total of 0.00 from holding Enveric Biosciences or generate 0.0% return on investment in Enveric Biosciences over 30 days. Enveric Biosciences is related to or competes with Ocean Biomedical, Hepion Pharmaceuticals, Elevation Oncology, and Zura Bio. Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care More
Enveric Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Enveric Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Enveric Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 65.81 | |||
| Value At Risk | (13.40) | |||
| Potential Upside | 9.78 |
Enveric Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enveric Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Enveric Biosciences' standard deviation. In reality, there are many statistical measures that can use Enveric Biosciences historical prices to predict the future Enveric Biosciences' volatility.| Risk Adjusted Performance | (0.16) | |||
| Jensen Alpha | (1.87) | |||
| Total Risk Alpha | (1.92) | |||
| Treynor Ratio | 14.7 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enveric Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enveric Biosciences Backtested Returns
Enveric Biosciences secures Sharpe Ratio (or Efficiency) of -0.23, which denotes the company had a -0.23 % return per unit of risk over the last 3 months. Enveric Biosciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enveric Biosciences' Variance of 64.61, mean deviation of 4.63, and Standard Deviation of 8.04 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.13, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Enveric Biosciences are expected to decrease at a much lower rate. During the bear market, Enveric Biosciences is likely to outperform the market. At this point, Enveric Biosciences has a negative expected return of -2.0%. Please make sure to confirm Enveric Biosciences' kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Enveric Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.08 |
Virtually no predictability
Enveric Biosciences has virtually no predictability. Overlapping area represents the amount of predictability between Enveric Biosciences time series from 27th of January 2025 to 11th of February 2025 and 11th of February 2025 to 26th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Enveric Biosciences price movement. The serial correlation of 0.08 indicates that barely 8.0% of current Enveric Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | 0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Enveric Biosciences lagged returns against current returns
Autocorrelation, which is Enveric Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Enveric Biosciences' stock expected returns. We can calculate the autocorrelation of Enveric Biosciences returns to help us make a trade decision. For example, suppose you find that Enveric Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Enveric Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Enveric Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Enveric Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Enveric Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Enveric Biosciences Lagged Returns
When evaluating Enveric Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Enveric Biosciences stock have on its future price. Enveric Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Enveric Biosciences autocorrelation shows the relationship between Enveric Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Enveric Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Enveric Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enveric Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enveric Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enveric Biosciences Stock:Check out Enveric Biosciences Correlation, Enveric Biosciences Volatility and Enveric Biosciences Alpha and Beta module to complement your research on Enveric Biosciences. For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Enveric Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.